ACLASTA sol perf 5 mg/100ml amp 100 ml

7680573630014 CH-57363 M05BA08 07.99.0.

Reimbursement limitations:

ACLASTA3

Pour le traitement de l'ostéoporose documentée, de l'ostéoporose cortico-induite et de la maladie de Paget.

ACLASTA sol perf 5 mg/100ml amp 100 ml
ACLASTA sol perf 5 mg/100ml amp 100 ml
ACLASTA sol perf 5 mg/100ml amp 100 ml
1 / 3
google

Details

Product number
5736301
CPT
-
Packaging group
1 x 100 ml
Unit
Durchstechflasche(n)
Composition
acidum zoledronicum 5 mg ut acidum zoledronicum monohydricum, mannitolum, natrii citras dihydricus corresp. natrium 7 mg, aqua ad iniectabile, ad solutionem pro 100 ml.

Articles (1)

Aclasta, Infusionslösung
Infusionslösung
1 x 100 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
09/08/2024
Professional SmPC
Français
09/08/2024
Professional SmPC
Italien
09/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
7.0 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 254.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2007

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
57363
Drug name
Aclasta, Infusionslösung
Galenic form
LSINF
ATC Code
M05BA08
Authorization status
Z
Dispensation category
B
First authorization
07/11/2006
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Morbus Paget, postmenopausale Osteoporose

Packaging details

Description (FR)
ACLASTA sol perf 5 mg/100ml amp 100 ml
Description (DE)
ACLASTA Inf Lös 5 mg/100ml Amp 100 ml
Market launch
07/11/2006
Narcotic (BTM)
No

Available generics

Zoledronat Accord onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680670710015
CHF 131.55
View
Zoledronat Fresenius Onco, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680624810013
CHF 124.00
View
Zoledronat Onco Labatec 4 mg/5 ml, solution à diluer pour perfusion
GTIN: 7680630120014
CHF 134.10
View
Zoledronat OSTEO Labatec, solution pour perfusion
GTIN: 7680622570025
CHF 220.65
View
Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung
GTIN: 7680626260014
CHF 220.65
View
Zoledronat Osteo Spirig HC, Infusionslösung
GTIN: 7680663410014
CHF 220.65
View
Zoledronat-Teva onco, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680622000034
CHF 134.10
View
Zoledronsäure Onco Sandoz 4 mg / 100 ml, Infusionslösung
GTIN: 7680629320012
CHF 134.10
View
Zoledronsäure Onco Sandoz 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680626250015
CHF 134.10
View